Tivozanib Market Impact of AI and Automation The global Tivozanib market, valued at approximately USD 200 million in 2022, is projected to experience a robust growth trajectory. The compound is primarily utilized in the treatment of renal cell carcinoma, with an anticipated compound annual growth rate (CAGR) of 10% from 2022 to 2027. This growth… Continue reading Global Tivozanib Market Impact of AI and Automation